Improved Broad-Spectrum Antiviral Discovery

Pathogenic microbes evolve quickly, and bad actors may exploit biotechnology for harmful purposes. Our current defenses struggle to keep pace with these evolving threats.

Global health outcomes are compromised by insufficient health systems and infrastructure that limit our ability to prevent and control infectious diseases. Key deficiencies include the lack of cost-effective antimicrobial materials to block pathogen transmission, underdeveloped intervention models for effective public health strategies, and outdated sanitation solutions that fail to meet the needs of vulnerable populations.